Clinicians have to think outside the box to identify rare cases of atypical haemolytic uraemic syndrome (aHUS) in a timely manner – but it’s key to getting patients onto early effective treatment and improving outcomes. In an Alexion-sponsored Satellite Symposium at the XXVII Congress of the International Society on Thrombosis and Haemostasis (ISTH), Professor Marie ...
Experts give top tips on identifying and treating aHUS
25 Jul 2019
Sponsored by Alexion Pharmaceuticals Australasia Pty Ltd